Cargando…

Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019

IMPORTANCE: The US spends far more on brand-name prescription drugs than other comparable countries. However, studies of prescription drug spending in the US are often limited because there can be substantial differences in the confidential rebates that drug manufacturers pay to Medicaid vs other pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clemans-Cope, Lisa, Epstein, Marni, Banthin, Jessica, Kesselheim, Aaron S., Hwang, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857139/ https://www.ncbi.nlm.nih.gov/pubmed/36637815 http://dx.doi.org/10.1001/jamahealthforum.2022.5012

Ejemplares similares

Contextualizing the Price of Biosimilar Adalimumab Based on Historical Rebates for the Original Formulation of Branded Adalimumab
por: Dickson, Sean R., et al.
Publicado: (2023)

Hospital Prices in Medicaid Managed Care
por: Marr, Jeffrey, et al.
Publicado: (2023)

Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
por: Rome, Benjamin N., et al.
Publicado: (2021)

Excess Medicaid Payments and the Stock Prices of Drug Companies
por: Grant, William C.
Publicado: (2012)

Competition and price among brand-name drugs in the same class: A systematic review of the evidence
por: Sarpatwari, Ameet, et al.
Publicado: (2019)

Off-patent drugs at brand-name prices: a puzzle for policymakers
por: Tallapragada, Naren P.
Publicado: (2016)

Trends in Prices of Popular Brand-Name Prescription Drugs in the United States
por: Wineinger, Nathan E., et al.
Publicado: (2019)

Not as bad as you think: a comparison of the nutrient content of best price and brand name food products in Switzerland
por: Khalatbari-Soltani, Saman, et al.
Publicado: (2016)

Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study
por: Liu, Michael, et al.
Publicado: (2020)

Long-Term Medicaid Excess Payments from Alleged Price Manipulation of Generic Lorazepam
por: Bian, Boyang, et al.
Publicado: (2012)

Patients’ access to drugs with rebates in Switzerland – Empirical analysis and policy implications for drug pricing in Europe
por: Carl, David L, et al.
Publicado: (2021)

Product-Line Extensions and Pricing Strategies of Brand-Name Drugs Facing Patent Expiration
por: Hong, Song Hee, et al.
Publicado: (2005)

Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs
por: Wong, William Bruce, et al.
Publicado: (2023)

Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer
por: Hernandez, Inmaculada, et al.
Publicado: (2020)

Medicaid professional fees for treatment of opioid use disorder varied widely across states and were substantially below fees paid by medicare in 2021
por: Clemans-Cope, Lisa, et al.
Publicado: (2022)

Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years’ Experience 1991–2015
por: Almalki, Ziyad S., et al.
Publicado: (2016)

Medicaid Formulary Decisions and the Institute for Clinical and Economic Review: Abandoning Pseudoscience in Imaginary Pharmaceutical Pricing Claims
por: Langley, Paul C
Publicado: (2021)

Price perception and price appearance on repurchase intention of Gen Y: do brand experience and brand preference mediate?
por: Yasri, Yasri, et al.
Publicado: (2020)

Value-Added Selling: How to Sell More Profitably, Confidently, and Professionally by Competing on Value-Not Price
por: Reilly, Tom
Publicado: (2018)

High-Profit Selling: Win the Sale Without Compromising on Price
por: Hunter, Mark
Publicado: (2012)

Short-selling constraints as cause for price distortions: An experimental study
por: Hauser, Florian, et al.
Publicado: (2012)

"Sell an Ox" - The Price of Cure for Hepatitis C in Two Countries
por: Paltiel, Ora, et al.
Publicado: (2019)

Techno-economic analysis of the deacetylation and disk refining process: characterizing the effect of refining energy and enzyme usage on minimum sugar selling price and minimum ethanol selling price
por: Chen, Xiaowen, et al.
Publicado: (2015)

The new sell and sell short: how to take profits, cut losses, and benefit from price declines
por: Elder, Alexander
Publicado: (2011)

Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition
por: Zhang, James X.
Publicado: (2020)

Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
por: Aaron, Micah B., et al.
Publicado: (2021)

Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021
por: Shin, Young Eun, et al.
Publicado: (2023)

Stock market reaction to government policy on determining coal selling price
por: Sunardi, Sunardi, et al.
Publicado: (2023)

Legislating Medicaid: Considering Medicaid and Its Origins
por: Moore, Judith D., et al.
Publicado: (2005)

Drug Expenditure, Price, and Utilization in US Medicaid: A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022
por: Alrasheed, Marwan, et al.
Publicado: (2023)

Availability of comparative real-world evidence research in Medicare patients: implications for Centers for Medicare and Medicaid Services drug price negotiations
por: Jaksa, Ashley, et al.
Publicado: (2023)

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
por: Sarpatwari, Ameet, et al.
Publicado: (2016)

The Impact of Medicaid Expansion on Medicaid Focused Insurers in California
por: McCue, Michael J.
Publicado: (2015)

Anticipated efficiencies, real costs: Medicaid managed care organizations and the pharmacy benefit
por: Bendicksen, Liam, et al.
Publicado: (2022)

Association Between Medicaid Waivers and Medicaid Disenrollment Among Autistic Adolescents During the Transition to Adulthood
por: Carey, Meghan E., et al.
Publicado: (2023)

Home makeovers that sell: quick and easy ways to get the highest possible price
por: Davis, Sid
Publicado: (2007)

Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients
por: Zhai, Mike Z., et al.
Publicado: (2022)

Medicaid at Forty
por: Rowland, Diane
Publicado: (2005)

Medicaid Drugs
por: Poisal, John A.
Publicado: (2004)

Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020
por: Liu, Patrick, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oolnaq5ke6ia9v5hu2g3mapd8f